GlaxoSmithKline
GSK
#212
Rank
A$147.04 B
Marketcap
A$72.80
Share price
2.39%
Change (1 day)
34.64%
Change (1 year)

Market capitalization of GlaxoSmithKline (GSK)

Market cap: A$147.04 Billion

As of December 2025 GlaxoSmithKline has a market cap of A$147.04 Billion. This makes GlaxoSmithKline the world's 212th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of GlaxoSmithKline from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025A$147.04 B31.54%
2024A$111.78 B-0.12%
2023A$111.92 B5.88%
2022A$105.70 B-29.76%
2021A$150.49 B26.11%
2020A$119.34 B-28.21%
2019A$166.23 B24.66%
2018A$133.34 B18.14%
2017A$112.87 B-13.65%
2016A$130.71 B-3.87%
2015A$135.97 B6.83%
2014A$127.28 B-12%
2013A$144.63 B42.11%
2012A$101.77 B-9.41%
2011A$112.34 B11.99%
2010A$100.31 B-17.82%
2009A$122.07 B-10.9%
2008A$137.00 B-13.69%
2007A$158.74 B-17.59%
2006A$192.61 B-4.36%
2005A$201.40 B10.78%
2004A$181.80 B2.62%
2003A$177.16 B-11.54%
2002A$200.27 B-33.53%
2001A$301.30 B-4.37%
2000A$315.07 B103.55%
1999A$154.78 B-24.78%
1998A$205.77 B56.66%
1997A$131.34 B85.38%
1996A$70.85 B

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of GlaxoSmithKline was reported to be:

A$145.03 Billion
by Nasdaq info icon info icon
A$144.02 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AstraZeneca
AZN
A$426.76 B 190.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
A$220.46 B 49.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$366.78 B 149.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$378.70 B 157.54%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$177.18 B 20.49%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
A$51.41 B-65.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
A$1.92 B-98.69%๐Ÿ‡บ๐Ÿ‡ธ USA